Trends in the Source of Prescription Drugs for Misuse between 2015 and 2019

References

• Abayateye, F., Fornssler, B., Feng, C., D’Arcy, C., & Alphonsus, K. (2022). Prescription drug misuse among adults in Canada: A scoping review. Journal of Substance Use, 1–10. https://doi.org/10.1080/14659891.2022.2053890
   Google Scholar
• Arens, A. M., van Wijk, X. M., Vo, K. T., Lynch, K. L., Wu, A. H., & Smollin, C. G. (2016). Adverse effects from counterfeit alprazolam tablets. JAMA Internal Medicine, 176(10), 1554–1555. https://doi.org/10.1001/jamainternmed.2016.4306
   PubMed Web of Science ®Google Scholar
• Becker, W. C., Fiellin, D. A., & Desai, R. A. (2007). Non-medical use, abuse and dependence on sedatives and tranquilizers among US adults: Psychiatric and socio-demographic correlates. Drug and Alcohol Dependence, 90(2-3), 280–287. https://doi.org/10.1016/j.drugalcdep.2007.04.009
   PubMed Web of Science ®Google Scholar
• Becker, W. C., Sullivan, L. E., Tetrault, J. M., Desai, R. A., & Fiellin, D. A. (2008). Non-medical use, abuse and dependence on prescription opioids among US adults: Psychiatric, medical and substance use correlates. Drug and Alcohol Dependence, 94(1-3), 38–47. https://doi.org/10.1016/j.drugalcdep.2007.09.018
   PubMed Web of Science ®Google Scholar
• Benson, K., Flory, K., Humphreys, K. L., & Lee, S. S. (2015). Misuse of stimulant medication among college students: A comprehensive review and meta-analysis. Clinical Child and Family Psychology Review, 18(1), 50–76. https://doi.org/10.1007/s10567-014-0177-z
   PubMed Web of Science ®Google Scholar
• Blakey, K., Thompson, A., Matheson, A., & Griffiths, A. (2022). What’s in fake ‘Xanax’?: A dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets. Drug Testing and Analysis, 14(3), 525–530. https://doi.org/10.1002/dta.3119
   PubMed Web of Science ®Google Scholar
• Bohnert, A. S., Guy, G. P., Jr,., & Losby, J. L. (2018). Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention’s 2016 opioid guideline. Annals of Internal Medicine, 169(6), 367–375. https://doi.org/10.7326/M18-1243
   PubMed Web of Science ®Google Scholar
• Boyd, C. J., Cranford, J. A., & McCabe, S. E. (2016). Longitudinal trajectories of non-medical use of prescription medication among middle and high school students. Journal of Addictive Diseases, 35(4), 258–265. https://doi.org/10.1080/10550887.2016.1186413
   PubMed Web of Science ®Google Scholar
• Boyd, C. J., Teter, C. J., West, B. T., Morales, M., & McCabe, S. E. (2009). Non-medical use of prescription analgesics: A three-year national longitudinal study. Journal of Addictive Diseases, 28(3), 232–242. https://doi.org/10.1080/10550880903028452
   PubMed Web of Science ®Google Scholar
• Brunetti, P., Giorgetti, R., Tagliabracci, A., Huestis, M. A., & Busardò, F. P. (2021). Designer benzodiazepines: A review of toxicology and public health risks. Pharmaceuticals, 14(6), 560.
   Google Scholar
• Center for Disease Control. (2020). Conducting trend analyses of YRBS data. https://www.cdc.gov/healthyyouth/data/yrbs/pdf/2019/2019_YRBS_Conducting_Trend_Analyses.pdf
   Google Scholar
• Choi, N. G., DiNitto, D. M., & Choi, B. Y. (2021). Prescription pain reliever use and misuse among cannabis users aged 50+ years. Clinical Gerontologist, 44(1), 53–65. https://doi.org/10.1080/07317115.2020.1757540
   PubMed Web of Science ®Google Scholar
• Chua, K. P., Brummett, C. M., Conti, R. M., & Bohnert, A. S. (2021). Opioid prescribing to US children and young adults in 2019. Pediatrics, 148(3), e2021051539. https://doi.org/10.1542/peds.2021-051539
   Google Scholar
• Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA, 315(15), 1624–1645. https://doi.org/10.1001/jama.2016.1464
   PubMed Web of Science ®Google Scholar
• Fergus, K. B., Schwab, M. E., Butler, C., Cattle, C. J., Breyer, B. N., Copp, H. L., & Nagata, J. M. (2022). Young adult healthcare exposure and future opioid misuse: A prospective cohort study. American Journal of Preventive Medicine, 62(6), 914–920. https://doi.org/10.1016/j.amepre.2021.12.026
   PubMed Web of Science ®Google Scholar
• Ford, J. A., Hinojosa, M. S., & Nicholson, H. L. (2018). Disability status and prescription drug misuse among US adults. Addictive Behaviors, 85, 64–69. https://doi.org/10.1016/j.addbeh.2018.05.019
   PubMed Web of Science ®Google Scholar
• Ford, J. A., & Lacerenza, C. (2011). The relationship between source of diversion and prescription drug misuse, abuse, and dependence. Substance Use & Misuse, 46(6), 819–827. https://doi.org/10.3109/10826084.2010.538461
   PubMed Web of Science ®Google Scholar
• Ford, J. A., Pomykacz, C., Szalewski, A., Esteban McCabe, S., & Schepis, T. S. (2020). Friends and relatives as sources of prescription opioids for misuse among young adults: The significance of physician source and race/ethnic differences. Substance Abuse, 41(1), 93–100. https://doi.org/10.1080/08897077.2019.1635955
   PubMed Web of Science ®Google Scholar
• Goldstick, J. E., Guy, G. P., Losby, J. L., Baldwin, G., Myers, M., & Bohnert, A. S. (2021). Changes in initial opioid prescribing practices after the 2016 release of the CDC guideline for prescribing opioids for chronic pain. JAMA Network Open, 4(7), e2116860-e2116860. https://doi.org/10.1001/jamanetworkopen.2021.16860
   Web of Science ®Google Scholar
• Gollust, S. E., & Haselswerdt, J. (2021). A crisis in my community? Local-level awareness of the opioid epidemic and political consequences. Social Science & Medicine (1982), 291, 114497. https://doi.org/10.1016/j.socscimed.2021.114497
   PubMed Web of Science ®Google Scholar
• Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. (2017). Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health. Annals of Internal Medicine, 167(5), 293–301. https://doi.org/10.7326/m17-0865
   PubMed Web of Science ®Google Scholar
• Holland, K. M., Jones, C., Vivolo-Kantor, A. M., Idaikkadar, N., Zwald, M., Hoots, B., Yard, E., D’Inverno, A., Swedo, E., Chen, M. S., Petrosky, E., Board, A., Martinez, P., Stone, D. M., Law, R., Coletta, M. A., Adjemian, J., Thomas, C., Puddy, R. W., … Houry, D. (2021). Trends in US emergency department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic. JAMA Psychiatry, 78(4), 372–379. https://doi.org/10.1001/jamapsychiatry.2020.4402
   PubMed Web of Science ®Google Scholar
• Johnson, J., Pizzicato, L., Johnson, C., & Viner, K. (2021). Increasing presence of xylazine in heroin and/or fentanyl deaths, Philadelphia, Pennsylvania, 2010–2019. Injury Prevention: Journal of the International Society for Child and Adolescent Injury Prevention, 27(4), 395–398. https://doi.org/10.1136/injuryprev-2020-043968
   PubMed Web of Science ®Google Scholar
• Kelley-Quon, L. I., Kirkpatrick, M. G., Ricca, R. L., Baird, R., Harbaugh, C. M., Brady, A., Garrett, P., Wills, H., Argo, J., Diefenbach, K. A., Henry, M. C. W., Sola, J. E., Mahdi, E. M., Goldin, A. B., St Peter, S. D., Downard, C. D., Azarow, K. S., Shields, T., & Kim, E. (2021). Guidelines for opioid prescribing in children and adolescents after surgery: An expert panel opinion. JAMA Surgery, 156(1), 76–90. https://doi.org/10.1001/jamasurg.2020.5045
   PubMed Web of Science ®Google Scholar
• Lee, B., Zhao, W., Yang, K. C., Ahn, Y. Y., & Perry, B. L. (2021). Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018. JAMA Network Open, 4(2), e2036687-e2036687. https://doi.org/10.1001/jamanetworkopen.2020.36687
   Web of Science ®Google Scholar
• Lipari, R. N., & Hughes, A. (2017). How people obtain the prescription pain relievers they misuse. The CBHSQ report. Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Liu, S., O’Donnell, J., Matt Gladden, R., McGlone, L., & Chowdhury, F. (2021). Trends in nonfatal and fatal overdoses involving benzodiazepines—38 states and the District of Columbia, 2019–2020. American Journal of Transplantation, 21(11), 3794–3800. https://doi.org/10.1111/ajt.16053
   Web of Science ®Google Scholar
• Mathieu, C., Joly, P., Jacqmin-Gadda, H., Wanneveich, M., Bégaud, B., & Pariente, A. (2021). Patterns of benzodiazepine use and excess risk of all-cause mortality in the elderly: A nationwide cohort study. Drug Safety, 44(1), 53–62. https://doi.org/10.1007/s40264-020-00992-7
   PubMed Web of Science ®Google Scholar
• McCabe, S. E., Veliz, P., Wilens, T. E., West, B. T., Schepis, T. S., Ford, J. A., Pomykacz, C., & Boyd, C. J. (2019). Sources of nonmedical prescription drug misuse among US high school seniors: Differences in motives and substance use behaviors. Journal of the American Academy of Child and Adolescent Psychiatry, 58(7), 681–691. https://doi.org/10.1016/j.jaac.2018.11.018
   PubMed Web of Science ®Google Scholar
• Mowbray, O., & Quinn, A. (2015). Prescription pain reliever misuse prevalence, correlates, and origin of possession throughout the life course. Addictive Behaviors, 50, 22–27. https://doi.org/10.1016/j.addbeh.2015.06.006
   PubMed Web of Science ®Google Scholar
• Odani, S., Lin, L. C., Nelson, J. R., & Agaku, I. T. (2020). Misuse of prescription pain relievers, stimulants, tranquilizers, and sedatives among US older adults aged ≥ 50 years. American Journal of Preventive Medicine, 59(6), 860–872. https://doi.org/10.1016/j.amepre.2020.04.028
   PubMed Web of Science ®Google Scholar
• Pardo, B., Taylor, J., Caulkins, J., Reuter, P., & Kilmer, B. (2021). The dawn of a new synthetic opioid era: The need for innovative interventions. Addiction (Abingdon, England), 116(6), 1304–1312. https://doi.org/10.1111/add.15222
   PubMed Web of Science ®Google Scholar
• Peteet, B. J. (2019). Psychosocial risks of prescription drug misuse among US racial/ethnic minorities: A systematic review. Journal of Ethnicity in Substance Abuse, 18(3), 476–508. https://doi.org/10.1080/15332640.2017.1381662
   PubMed Web of Science ®Google Scholar
• Roelofs, C. (2022). Results of an opioid hazard awareness training intervention for stone, sand, and gravel miners. Mining, Metallurgy & Exploration, 39(1), 55–61. https://doi.org/10.1007/s42461-021-00515-7
   Web of Science ®Google Scholar
• Roelofs, C., Sugerman-Brozan, J., Kurowski, A., Russell, L., & Punnett, L. (2021). Promoting opioid awareness through a union-based peer training model. New Solutions: A Journal of Environmental and Occupational Health Policy : NS, 31(3), 286–297. https://doi.org/10.1177/1048291120982597
   PubMed Web of Science ®Google Scholar
• Schepis, T. S., & Krishnan-Sarin, S. (2008). Characterizing adolescent prescription misusers: A population-based study. Journal of the American Academy of Child & Adolescent Psychiatry, 47(7), 745–754.
   Google Scholar
• Schepis, T. S., & Krishnan-Sarin, S. (2009). Sources of prescriptions for misuse by adolescents: differences in sex, ethnicity, and severity of misuse in a population-based study. Journal of the American Academy of Child and Adolescent Psychiatry, 48(8), 828–836. https://doi.org/10.1097/chi.0b013e3181a8130d
   PubMed Web of Science ®Google Scholar
• Schepis, T. S., & McCabe, S. E. (2016). Trends in older adult nonmedical prescription drug use prevalence: Results from the 2002–2003 and 2012–2013 National Survey on Drug Use and Health. Addictive Behaviors, 60, 219–222. https://doi.org/10.1016/j.addbeh.2016.04.020
   PubMed Web of Science ®Google Scholar
• Schepis, T. S., McCabe, S. E., & Ford, J. A. (2022). Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex. The American Journal on Addictions, 31(5), 396–402. https://doi.org/10.1111/ajad.13289
   PubMed Web of Science ®Google Scholar
• Schepis, T. S., Teter, C. J., Simoni-Wastila, L., & McCabe, S. E. (2018). Prescription tranquilizer/sedative misuse prevalence and correlates across age cohorts in the US. Addictive Behaviors, 87, 24–32. https://doi.org/10.1016/j.addbeh.2018.06.013
   PubMed Web of Science ®Google Scholar
• Schepis, T. S., Wilens, T. E., & McCabe, S. E. (2019). Prescription drug misuse: Sources of controlled medications in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 58(7), 670–680.e4. https://doi.org/10.1016/j.jaac.2018.09.438
   PubMed Web of Science ®Google Scholar
• Schroeder, A. R., Dehghan, M., Newman, T. B., Bentley, J. P., & Park, K. T. (2019). Association of opioid prescriptions from dental clinicians for US adolescents and young adults with subsequent opioid use and abuse. JAMA Internal Medicine, 179(2), 145–152. https://doi.org/10.1001/jamainternmed.2018.5419
   PubMed Web of Science ®Google Scholar
• Schepis, T. S., & McCabe, S. E. (2019). Prescription Opioid misuse in us older adults: Associated comorbidities and reduced quality of life in the National Epidemiologic Survey of Alcohol and Related Conditions-III. The Journal of Clinical Psychiatry, 80(6), 13246.
   Google Scholar
• Seth, P., Rudd, R. A., Noonan, R. K., & Haegerich, T. M. (2018). Quantifying the epidemic of prescription opioid overdose deaths. American Journal of Public Health, 108(4), 500–502. https://doi.org/10.2105/ajph.2017.304265
   PubMed Web of Science ®Google Scholar
• Shapiro, A. P., Krew, T. S., Vazirian, M., Jerry, J., & Sola, C. (2019). Novel ways to acquire designer benzodiazepines: A case report and discussion of the changing role of the internet. Psychosomatics, 60(6), 625–629. https://doi.org/10.1016/j.psym.2019.02.007
   PubMed Web of Science ®Google Scholar
• StataCorp. (2017). Stata statistical software: Release 15. StataCorp LLC.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from the2019 National Survey on Drug Use and Health (HHS Publication No. PEP20‐07‐01‐001, NSDUH Series H‐55). Center for Behavioral Health Statistics and Quality.
   Google Scholar
• Tichy, E. M., Hoffman, J. M., Suda, K. J., Rim, M. H., Tadrous, M., Cuellar, S., Clark, J. S., Wiest, M. D., Matusiak, L. M., & Schumock, G. T. (2021). National trends in prescription drug expenditures and projections for 2021. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists, 78(14), 1294–1308. https://doi.org/10.1093/ajhp/zxab160
   PubMed Web of Science ®Google Scholar
• Tobias, S., Shapiro, A. M., Grant, C. J., Patel, P., Lysyshyn, M., & Ti, L. (2021). Drug checking identifies counterfeit alprazolam tablets. Drug and Alcohol Dependence, 218, 108300. https://doi.org/10.1016/j.drugalcdep.2020.108300
   PubMed Web of Science ®Google Scholar
• Votaw, V. R., Geyer, R., Rieselbach, M. M., & McHugh, R. K. (2019). The epidemiology of benzodiazepine misuse: A systematic review. Drug and Alcohol Dependence, 200, 95–114. https://doi.org/10.1001/jamanetworkopen.2020.28557
   PubMed Web of Science ®Google Scholar
• Xu, K. Y., Hartz, S. M., Borodovsky, J. T., Bierut, L. J., & Grucza, R. A. (2020). Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999-2015. JAMA Network Open, 3(12), e2028557. https://doi.org/10.1001/jamanetworkopen.2020.28557
   PubMed Web of Science ®Google Scholar
• Zullig, K. J., & Divin, A. L. (2012). The association between non-medical prescription drug use, depressive symptoms, and suicidality among college students. Addictive Behaviors, 37(8), 890–899. https://doi.org/10.1016/j.addbeh.2012.02.008
   PubMed Web of Science ®Google Scholar